Use of reconstituted metabolic networks to assist in metabolomic data visualization and mining by Jourdan, Fabien et al.
ORIGINAL ARTICLE
Use of reconstituted metabolic networks to assist in metabolomic
data visualization and mining
Fabien Jourdan • Ludovic Cottret • Laurence Huc • David Wildridge •
Richard Scheltema • Anne Hillenweck • Michael P. Barrett • Daniel Zalko •
David G. Watson • Laurent Debrauwer
Received: 8 June 2009/Accepted: 14 December 2009/Published online: 6 January 2010
 The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract Metabolomics experiments seldom achieve
their aim of comprehensively covering the entire metabo-
lome. However, important information can be gleaned even
from sparse datasets, which can be facilitated by placing
the results within the context of known metabolic net-
works. Here we present a method that allows the automatic
assignment of identiﬁed metabolites to positions within
known metabolic networks, and, furthermore, allows
automated extraction of sub-networks of biological
signiﬁcance. This latter feature is possible by use of a gap-
ﬁlling algorithm. The utility of the algorithm in recon-
structing and mining of metabolomics data is shown on two
independent datasets generated with LC–MS LTQ-Orbitrap
mass spectrometry. Biologically relevant metabolic sub-
networks were extracted from both datasets. Moreover, a
number of metabolites, whose presence eluded automatic
selection within mass spectra, could be identiﬁed retro-
spectively by virtue of their inferred presence through gap
ﬁlling.
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1 Introduction
Studies into metabolism have generally concentrated on
individual metabolic pathways with a focus on speciﬁc
metabolic functions (e.g. glycolysis). The development of
global and high throughput metabolomic techniques has
made it possible to investigate metabolism at the scale of
the global metabolic network, which is the union of all
pathways and can be formally deﬁned as ‘‘a collection of
objects and the relations among them. The objects corre-
spond to chemical compounds, biochemical reactions,
enzymes and genes’’ (Lacroix et al. 2008).
The representation proposed by the BioCyc Cellular
Overview is an increasingly popular style of visualising
individual pathways in many organisms (Paley and Karp
2006) (Fig. 1a, a0). Within the BioCyc architecture, nodes
belonging to different pathways are duplicated, since the
objective of that visualisation is to prioritise the pathway as
the central feature (see (Bourqui et al. 2007) for a discus-
sion on node duplication). Such duplication of nodes is
advantageous when considering individual pathways, but
fails to capture linkage information of metabolites
belonging to multiple pathways. Insight into the whole
network is gained by removing duplication and connecting
metabolites to all possible neighbours. However, this
results in a much higher complexity as can be seen in
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were coloured green (Fig. 1b, b0). Zooming into local parts
of the total representation reveals a dense mesh of edges,
caused by the high degree of connectivity across the net-
work (Jeong et al. 2000) (Fig. 1c, c0). This complexity
confounds the objective of creating interpretable meta-
bolomics networks. A major aim therefore, is to reduce the
complexity of the visual representations of metabolic net-
works, thus enabling extraction of relevant information. To
do so, we have developed a method that constructs a sub-
network containing the selected metabolites, regardless of
their occurrence in disparate metabolic pathways. Fig. 2
shows the result of this method (note that all of the iden-
tiﬁed metabolites are present in the drawing and most of
them are connected).
Truly comprehensive ‘‘metabolomic’’ data acquisition
does not yet exist. A variety of measurement tools (e.g.
LC–MS, GC–MS) and extraction methods (e.g. ethanol,
acetonitrile, methanol, water and various gradients) exist
(Fiehn 2001), but the combination of all approaches in
individual experiments is rarely possible. Networks built
solely on identiﬁed metabolites from such sparse datasets
have limits to their overall utility. Approaches where
inference is combined with observation, can, therefore, be
helpful in terms of data mining. Here we introduce a
methodology that applies such an approach to two datasets
acquired with the high-resolution LTQ-Orbitrap in an
LC–MS setup. The ﬁrst dataset is derived from the parasitic
protozoan Trypanosoma brucei, which is the causative
agent of human African trypanosomiasis (Barrett et al.
2007). The second dataset is derived from human liver
cells (HepG2). We were able to extract biologically rele-
vant metabolic sub-networks for both datasets. The gap
ﬁlling process allowed us to connect identiﬁed metabolites
and detection of metabolites that had been discarded during
the data pre-processing or simply were not detected due to
the LTQ-Orbitrap conﬁguration.
The algorithm presented in this article can be used on
our web server called MetExplore (http://metexplore.
toulouse.inra.fr/metexplore/).
Fig. 1 Each panel corresponds to one of two separate datasets: the
upperpanelisfromTrypanosmabruceiandthelowerfromHepG2cells
(human liver cells). a, a0 Parts of cellular overview diagram from
BioCyc, grey boxes represent pathways and green nodes identiﬁed
metabolites.b,b0 MetabolicnetworkvisualizedusingCytoscape,green
nodes are identiﬁed metabolites. c, c0 Zoomed in view of the network
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1232 Materials and methods
2.1 Metabolomics data generation and processing
2.1.1 Metabolite extraction from trypanosomes
Metabolite extraction and quantiﬁcation was performed as
described in (Kamleh et al. 2008).In brief, pooled cells
were pelleted at 1,250 RCF (4C, 10 min), re-suspended in
1 ml of serum free medium, and kept on ice whilst mea-
suring cell density. The volume was adjusted to a ﬁnal
concentration of 10
9 cells/ml, and the cells incubated at
28C for 30 min to allow steady-state metabolism to
re-establish. Total metabolites were extracted by adding
200 ll of concentrated cell suspension (at 10
9 cells/ml) to
800 ll of 100% ethanol at 80C for 2 min. For the mea-
surements, a ZIC-HILIC HPLC (5 lm 150 9 4.6 mm;
HiChrom, Reading UK) was coupled to an LTQ-Orbitrap
(Thermo Scientiﬁc). Both positive and negative ionization
centroid mode were registered in two separate runs, with a
mass scanning range of 50–1200 m/z and a resolution of
30,000.
2.1.2 Metabolite extraction from HepG2 cells
HepG2 cells were grown in DMEM medium supplemented
with FBS, L-glutamine, penicillin and streptomycin. Med-
ium was removed and kept at -20C (medium sample) and
cells were scraped into acetonitrile/water (50:50, v:v) and
frozen (cell sample). Medium and cell samples were con-
centrated under vacuum. Proteins were precipitated by
adding ethanol and centrifugation. Supernatants were
concentrated again by vacuum before LC–MS analysis. LC
was performed on a C18 column (2 mm I.D.) using H2O/
acetonitrile gradient elution.
Mass spectrometric data were generated on an LTQ-
Orbitrap hybrid instrument coupled to a Surveyor LC
system. Samples were diluted tenfold before injection
(10 ll) onto a Hypercarb LC column (Thermo Fisher, Les
Ulis, France). Compounds were separated using a water–
0.5% acetic acid (solvent A) and acetonitrile (solvent B)
gradient at a ﬂow rate of 0.2 ml/min by varying solvent B.
Mass spectrometric acquisition was carried out using
positive electrospray ionisation and collecting data from
m/z 100 to m/z 700 at a resolution power of 30,000. Exact
mass measurements were achieved by external calibration.
2.1.3 Data processing
Data for the HepG2 cell was recorded in proﬁle mode and
converted to centroid mode with ReadW (http://sashimi.
sourceforge.net/software_glossolalia.html). Signals were
extracted with a ‘‘greedy’’ approach, resulting in all real
signals but also a large number of noise signals. Signals
from technical and biological replicates were grouped
together into a replicate-set. For this project only repro-
ducible signals were considered of interest, expressed as a
RSD (Relative Standard Deviation) value of less than 35%.
The LTQ-Orbitrap is expected to quantify metabolites from
the same sample reproducibly within 20% (Shah et al.
2000), which was extended to take minor biological vari-
ation into account. After this step the replicate sets are
Fig. 2 a Trypanosoma brucei metabolic network (derived from the
BioCyc database) with identiﬁed metabolites highlighted in green. b
Sub-network extracted by our method where all the identiﬁed
metabolites are present (green nodes), reactions and metabolites,
whose presence is inferred based on the BioCyc reconstruction, were
added to create a pseudo-complete and descriptive sub-network
(smaller nodes)
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123combined into one global set. Peaks removed by the RSD
ﬁlter matching reproducible peaks of the other set were
recovered. The remaining noise was removed with the
CoDA-DW approach (Windig et al. 2005). As a last
measure extensive de-isotoping and other related peak
removal based on correlation analysis of intensity patterns
and peak shapes is performed (Scheltema et al.; bioanalysis
December 2009—in press), ensuring that mostly signals of
interest are included for further analysis.
2.2 Metabolic networks
2.2.1 Mass mapping
High resolution mass spectrometry facilitates identiﬁcation
of metabolites by exact mass mapping to, for example, the
KEGG database (Breitling et al. 2006). This mapping is not
completely satisfactory as isomeric compounds (e.g. fruc-
tose and glucose) cannot be discriminated, unless standard
compounds are used as reference for retention time
comparison, or use of orthogonal approaches such as
fragmentation patterns generated by tandem mass spec-
trometry. In addition, the electrospray ionisation process is
known to be subject to matrix effects and ion suppression
(Annesley 2003) and to some selectivity, thus hindering
collection of certain compounds (Cech and Enke 2001). In
our approach we chose to take all the possible isomers for a
given exact mass into account as a ﬁrst approximation,
with a user deﬁnable mass range of 2 ppm. This approach
is similar to that proposed in Masstrix (Suhre and Schmitt-
Kopplin 2008), which is a web server allowing mass
mapping to KEGG maps. To circumvent the limitations of
mass mapping, however, the application can also be sup-
plied with a list of BioCyc identiﬁers instead of the masses.
In this case it is assumed that the user has made a correct
interpretation of the mass spectrum.
2.2.2 Network reconstruction
Both networks were derived from metabolic reconstruc-
tions made by the Pathologic tool used to build BioCyc-
like databases (Karp et al. 2002). This tool determines a
putative list of biochemical reactions by comparing a list of
around 7,500 genes (from curated metabolic data of more
than 1,600 organisms) with assigned enzymatic functions
to the genome of the organism in question. The appropriate
data for Trypanosoma brucei and Human dataset was
derived from TrypanoCyc (Chukualim et al. 2008) and
HumanCyc (Romero et al. 2005) respectively.
2.2.3 Graph model and ﬁltering
The metabolic network was modelled as a bipartite graph,
which is composed of two types of nodes: corresponding
here respectively to the reactions and to the metabolites
(see Fig. 3). There is an edge between a metabolite and a
reaction node if the metabolite is a substrate of the reaction,
and there is an edge between a reaction and a metabolite
node if the reaction produces the metabolite. Each edge has
an arrow indicating its relation to the reaction and reaction
nodes are ﬁlled with a colour according to their revers-
ibility. Unlike simple metabolic graphs, which are char-
acterised by a single type of node (compounds or
reactions), the models represented here depict the complete
linkage pattern between the set of substrates and the set of
products of a reaction. In those cases where the direction of
the reaction is not strictly deﬁned in the metabolic
Fig. 3 The upper panel shows
a textual description of a
reaction. The lower panel shows
the bipartite graph modelling of
this reaction. Blue nodes are
metabolite and the pink node is
the reaction. Arrows indicate the
direction of a reaction, but in
that case the reaction is
reversible which is indicated by
red border of the reaction node
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123databases, the direction is determined as follows: if a
reaction occurs in the same direction, whatever the meta-
bolic pathway in MetaCyc, then the reaction is considered
irreversible and a direction is assigned. Conversely, if a
reaction occurs in two directions according to MetaCyc
pathway attributes, then the reaction is assigned as
reversible. As any reaction can be reversible under the
correct thermodynamic conditions we conﬁne ourselves, in
this ﬁrst approximation, to database assignments on
reversibility, although manual curation is possible.
To obtain a faithful and interpretable metabolic network
it is necessary to apply ﬁlters to the primary network built
on all metabolites and reactions listed in a database. For
example nodes that short circuit the network (e.g. water
and the common ‘‘currency metabolites’’ including ATP,
ADP, NAD(H), NADP(H) and other cofactors) as well as
higher molecular weight cellular components (nucleic
acids, proteins, glycoconjugates etc.) must be pruned (Arita
2004). For this purpose, we used a published list of 59
cofactor transformations (Handorf et al. 2008), of which 32
were present in the T. brucei network and 44 in the Homo
sapiens network. The reduced T. brucei metabolic network
contains 925 reactions, 922 compounds,and 2113 edges and
the reduced Homo sapiens metabolic network (considered
here as the HepG2 network) contains 1,416 reactions, 1,402
compounds, and 3,379 edges. Finally, the ﬁltered metabolic
network was exported into edge-lists and attribute ﬁles,
which can be read by the biochemical network visualization
software Cytoscape (Shannon et al. 2003).
2.3 Metabolic sub-network extraction and gap ﬁlling
2.3.1 Sub-network extraction
The simplest method of extracting sub-networks involves
retaining only those metabolites identiﬁed in a given
experiment. In this case a reaction is kept when its sub-
strates and products are present in the set of all identiﬁed
metabolites (for example see Fig. 4a, c). However, such a
sub-network can be very sparse and difﬁcult to interpret.
For instance, when applying this method to the T. brucei
dataset, 17 of the 91 identiﬁed metabolites are not con-
nected to any other metabolites (isolated nodes on Fig. 4c)
and thus cannot be integrated directly into a metabolic
reaction or a metabolic process. To overcome this problem
we propose to extend the sub-network extraction using a
gap ﬁlling algorithm.
2.3.2 Gap ﬁlling
Several methods already exist for ﬁnding paths between
two metabolites (Arita 2000; Rahman et al. 2005).
However, these methods do not check the availability of
the co-substrates, while in fact a reaction should be taken
Fig. 4 a Sub-network extracted
with only identiﬁed compounds
for HepG2 cells. b Sub-network
with gaps ﬁlled for HepG2 cells.
c Sub-network extracted with
only identiﬁed compounds for
the trypanosome. d Sub-
network with gap ﬁlled for the
trypanosome
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123into account if all its co-substrates are present. For instance
in Fig. 5b metabolite H belongs to a path connecting E and
I, but the reaction requires F if it is to be ﬁred. This notion
of co-substrate necessity is used by the method which looks
for the scope of a set of compounds, where the scope is the
set of compounds that can be produced from a set of seed
compounds (Handorf et al. 2005). The method to compute
such a scope is iterative. At each iteration, the reactions are
considered and found feasible (ﬁred) if all of its substrates
are in the seed set. When this is the case, all of the products
of the reactions are added to the seed set and the method
re-iterates. The process stops when the last iteration fails to
ﬁre any reaction. Figure 5c shows the scope on a set of
identiﬁed compounds, note that H is not in the scope as F is
not an available compound.
Our approach improves this since we do not take
metabolites into account that are not on the path between
two identiﬁed metabolites. For instance metabolites D and
G in Fig. 5 will not be selected. The adapted scope algo-
rithm works as follows. For each identiﬁed metabolite we
look at all of the reactions that use this metabolite as a
substrate. If all of the other substrates of this reaction are
present in the dataset, we consider all of the products of the
reaction as potential candidates. For each of these candi-
dates, we search the list of all reactions for which the
candidate is a substrate. If for at least one of these reactions
all required substrates and products are present in the
dataset, we consider that the metabolite in question is a
relevant candidate. Finally, we add both the candidate
metabolite and the associated reactions which helped us to
localise it in the sub-network of the previous iteration.
With this method only single metabolite gaps are captured,
but by rerunning the process multiple times larger gaps can
be ﬁlled. We have tried this, however the signiﬁcance of
these results (discussed in the next section) and the bio-
logical relevance of networks built with a single gap barely
improved on subsequent iterations.
3 Results and discussion
3.1 Statistical signiﬁcance of sub-networks
In order to asses the quality of sub-networks we compute
their statistical signiﬁcance. The P-values obtained mea-
sure the probability that a random set of metabolites results
in a more connected sub-network than one computed using
the measured dataset. This is similar to the approach pre-
sented by (Antonov et al. 2009). However, our method can
result in multiple separately connected components, mak-
ing it necessary to analyze the sub network individually.
On the two datasets presented here, a single iteration of the
gap ﬁlling algorithm resulted in a signiﬁcant p-value of
below 0.01 (verbatim use of the algorithm presented by
Antonov et al. resulted in similar signiﬁcance). When
iterating the process P-values below 0.01 were also found.
Fig. 5 Different options to
connect identiﬁed metabolites. a
The input network where green
nodes are identiﬁed metabolites.
b Purple nodes belong to simple
paths between identiﬁed
metabolites. c Purple nodes
belong to the scope of all the
identiﬁed metabolites. d Purple
nodes belong to a path deﬁned
by our gap ﬁlling algorithm
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1233.2 Obtaining improved connectivity
Figure 4b and d show the result of our algorithm on the two
different datasets studied here. For the T. brucei dataset
(Fig. 4c, d) the number of unconnected compounds reduces
from 17 to 9. The number of connected components (i.e. a
sub-network in which any two nodes are connected by
paths) is 17 (as opposed to 27 before application of the
algorithm). For the HepG2 dataset the number of uncon-
nected compounds reduces from 22 to 17. The number of
connected components is 20 (as opposed to 27 before
application of the algorithm). A comparison was also made
for multiple iterations of the gap-ﬁlling procedure. How-
ever, the gain of connectivity was low, while the sub-net-
work grew denser at each iteration (data not shown).
3.3 Biological relevance of sub-networks
Trypanosomes contain an unusual ‘‘signature’’ metabolite,
trypanothione, that comprises two molecules of glutathione
linked through a spermidine. Its presence, along with
metabolites involved in its biosynthesis, offers an inter-
esting proof of concept for the pathway extraction method.
Fig. 6 shows that the trypanothione biosynthetic pathway
sub-network was indeed correctly extracted.
The HepG2 cells were derived from a human hepatocel-
lular carcinoma and are a commonly used hepatocyte model
cell line. The subnetworks we extracted dealt with major
hepatic metabolic pathways, such as deamination of amino-
acids and catabolism of nucleic acids. We identiﬁed some
metabolites from the urea cycle (including citrulline and
arginine), which occurs speciﬁcally in the liver. Moreover,
glutamine and glutamate were also present in the liver.
Finally, metabolites associated with purine (Fig. 7a) and
pyrimidine (Fig. 7b) pathways were detected (adenosine,
hypoxanthine,cytosineanduracil).Thesepathwaysarelinked
by ribose 1-phosphate (whose presence is inferred from the
reconstruction method) and also converge in production of
ammoniawhosepresenceisalsoinferred(ammoniabeingtoo
small to be found in the mass spectrometry experiments used
here) and links the urea cycle and glutamate metabolism in
liver. This demonstrates how sparse datasets can be linked
across modules using the automated procedure outlined here.
3.4 The gap ﬁlling process enhances metabolomics raw
data processing
To obtain a comprehensive view using mass spectrometry
requires a combination of different sample preparation
techniques, solvents, chromatography types and detection
systems. Comprehensive metabolomics is thus seldom, if
ever, possible for most experimental setups. An example of
such a sparse collection is the HepG2 dataset, which was
acquired only in positive ionisation mode with a mass range
of100–700amu.Thusallmetabolitesexclusivelydetectable
innegativeionisationmodeoroutsidethemassrangearenot
included in the dataset. Additionally, a number of metabo-
lites were removed from the dataset by the pre-processing
method.However,byexploitingthegapﬁllingprocessitwas
possible to extract parts of the network which contained
precisely those metabolites (see Table 1 for a complete
overview). For example, several acidic compounds such as
2-keto-6-aminocaproate, 4-(3-pyridyl)-3-butenoate, O-suc-
cinyl-homoserine or phosphorylated compounds were not
Fig. 6 Green nodes are metabolites identiﬁed in the dataset. Purple
nodes are the ones inferred by our gap ﬁlling method. Square nodes
are reactions nodes, when the border is red it means that the reaction
can occur in both directions. This pathway is part of amino acids
degradation. The sub-network reported here was produced from the
current version of Trypanocyc. It is notable that this version has not
beneﬁted from expert pruning so the reactions catalysed by spermine
synthase and spermidine dehydrogenase have not been reported in T.
brucei. Furthermore the reaction catalysed by trypanothione reduc-
tase, usually converts the oxidised form of trypanothione to its
reduced form, which is then involved in multiple cellular reductions
prior to its being enzymatically reconverted to the reduced form
318 F. Jourdan et al.
123observed, likely due to unfavourable ionisation conditions
(althoughtheseconditionsnotablydidallowthedetectionof
phenylpyruvate)whiletheirpresencecouldbeinferredbased
on the presence of observed masses and using the gap-ﬁlling
algorithm within the context of the known metabolic
network.
Fig. 7 Sub-networks for
HepG2 cell experiment. a
Purine pathway. b Pyrimidine
pathway
Table 1 List of predicted metabolites using the gap ﬁlling method
Name Formula Mass
a Observation
Ammonia H3N1 17.02600 Below mass acquisition range
Acetaldehyde C2H4O1 44.02567 Below mass acquisition range
Glycine C2H5N1O2 75.03148 Below mass acquisition range
L-Alanine C3H7N1O2 89.04713 Bellow mass acquisition range
Dihydrouracil C4H6N2O2 114.04238 Observed
5-Aminopentanamide C5H12N2O1 116.09441 Observed
L-Cysteine C3H7N1O2S1 121.01920 Observed
L-Glutamate gamma-semialdehyde C5H9N1O3 131.05769 Observed
L-Homocysteine C4H9N1O2S1 135.03485 Not observed in positive mode
2-Keto-6-aminocaproate C6H11N1O3 145.07334 Not observed in positive mode
4-(3-Pyridyl)-3-butenoate C9H9N1O2 163.06278 Not observed in positive mode
Phenylpyruvate C9H8O3 164.04680 Observed
O-Phospho-L-homoserine C4H10N1O6P1 199.02402 Not observed in positive mode
Deoxyribose 1-phosphate C5H11O7P1 214.02369 Not observed in positive mode
O-Succinyl-L-homoserine C8H13N1O6 219.07374 Not observed in positive mode
Ribose 1-phosphate C5H11O8P1 230.01861 Not observed in positive mode
Deoxyadenosine C10H13N5O3 251.10129 Observed
Inosine 50-phosphate C10H13N4O8P1 348.04655 Not observed in positive mode
The last column presents the result of the mass spectrometric analysis based on the detection of metabolite MH
? ions
a Calculated mass for the considered metabolite (the searched m/z ratio were 1.00723 mass unit above due to protonation)
Use of reconstituted metabolic networks 319
1233.5 Reducing network analysis complexity through
enhanced visualization
The two examples we described above show that our
method allows improved biological interpretation of data-
sets as well as providing a convenient and accessible means
for visualisation. By presenting data within the context of
the global metabolic network, rather than the fragmented
pathway representation, characteristic of other metabolic
pathway visualisation tools (e.g. BioCyc (Karp et al. 2005)
and KEGG (Aoki and Kanehisa 2005; Kanehisa et al. 2004;
Okuda et al. 2008), the new method permits enhanced
contextualisation of identiﬁed metabolites. This can be
particularly useful when considering subsets of the organ-
ism’s total metabolic potential as is usually seen in cell-
type speciﬁc expression patterns. With the integration of
our method into Cytoscape (which already offers many
functions to represent biological networks) and the ability
to import datasets, we offer a very easily navigable tool to
visualise and mine metabolomics datasets.
Recently, Antonov et al. (2009) proposed a web tool
which also offers the capability of highlighting metabolites
identiﬁed in metabolomics experiments within the context
of known metabolic pathways. However, this graph model
does not take the plurality of the substrates in a reaction
into account. So far our approach is restricted to a single
reaction gap, while Antonov et al. permit multiple absent
steps by using a shortest path principle. Clearly additional
routes to gap ﬁlling are desirable for these types of visu-
alization and this will be a focus of our continuing efforts
in this area.
4 Concluding remarks
Metabolic networks provide what is, arguably, the best
context for interpretation of metabolomics data. Classical
approaches consist of highlighting metabolites within the
represented global network. However, this generally results
in a representation overload, in which individual metabolic
processes cannot be readily traced. Our aim was to lower
the complexity of the network structure that connects
compounds in a given experiment. We propose an
approach based on sub-network extraction and a gap ﬁlling
algorithm, which takes reaction direction and substrate
availability into account. As we have shown, such an
approach helps in creating a connected sub-network, while
also resulting in a better interpretation of data acquired in
metabolomics experiments. Based on the investigated data,
we were able to identify biologically relevant sub-net-
works. Moreover, manual data mining in the raw spectra
conﬁrmed that those metabolites identiﬁed by the gap
ﬁlling algorithm were relevant to the context of those
experimentally measured. Some metabolites remain un-
connected using our approach and we plan future devel-
opments to allow use of multiple steps in ﬁlling gaps
between metabolites. A part of this effort will be directed
towards taking localisation of metabolites within cells into
account. It is important to recognise that even Orbitrap
data, with mass accuracies better than 1 ppm and resolution
up to 600,000 requires orthogonal approaches to provide
true identiﬁcation of metabolites. The algorithm itself
works well and users must ensure the robustness of their
metabolite identiﬁcation in exploiting the tool.
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